Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Albany Molecular Res (AMRI) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 784,050
  • Shares Outstanding, K 42,880
  • Annual Sales, $ 402,360 K
  • Annual Income, $ -2,300 K
  • 36-Month Beta 1.24
  • Price/Sales 1.55
  • Price/Book 2.32

Price Performance

See More
Period Period Low Period High Performance
1-Month
17.71 +2.43%
on 12/21/16
19.35 -6.25%
on 01/05/17
-0.05 (-0.27%)
since 12/13/16
3-Month
14.27 +27.12%
on 11/03/16
19.35 -6.25%
on 01/05/17
+1.68 (+10.21%)
since 10/13/16
52-Week
12.45 +45.70%
on 05/12/16
19.35 -6.25%
on 01/05/17
+0.96 (+5.59%)
since 01/13/16

Most Recent Stories

More News
Nemus Bioscience Announces License of Biosynthetic Technology from Teewinot Life Sciences to Manufacture its Proprietary Cannabinoid Molecules

COSTA MESA, CA / ACCESSWIRE / December 20, 2016 / NEMUS Bioscience, Inc. (OTCQB: NMUS) announced it has signed a definitive license agreement for rights to Teewinot Life Sciences Corp.'s patented biosynthetic...

AMRI CEO to Present at 35th Annual J.P. Morgan Healthcare Conference

Albany Molecular Research Inc. (NASDAQ: AMRI) announced today that William S. Marth, AMRI's President and Chief Executive Officer, will present at the 35th Annual J.P. Morgan Healthcare Conference on Wednesday,...

AMRI to Present Two Posters at AAPS 2016

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual Meeting and Exposition, at the Colorado Convention Center...

AMRI Announces Third Quarter 2016 Results

AMRI (NASDAQ: AMRI) today reported financial and operating results for the third quarter ended September 30, 2016 and reiterated its outlook for 2016.

AMRI Schedules Third Quarter 2016 Earnings Release and Conference Call

AMRI (NASDAQ: AMRI) today announced it will issue third quarter 2016 financial results before the opening of the market on Tuesday, November 8, 2016. Following the release of its results, the company will...

AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

AMRI , a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio of active pharmaceutical ingredients (APIs) and capabilities at CPhI Worldwide,...

AMRI to Unveil Powerful Portfolio of APIs and Capabilities at CPhI in Barcelona

AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be showcasing its comprehensive portfolio of active pharmaceutical ingredients (APIs) and capabilities at CPhI...

SSCI to Host Special Topic Presentations on Pharmaceutical Cocrystals as Drug Substance and the Implications of the Latest FDA Guidance

SSCI, a division of Albany Molecular Research, Inc. is pleased to see the US Food and Drug Administration (FDA) recently take the important step to revise the draft guidance to the industry on the regulatory...

Whitehouse Laboratories to Exhibit at the PDA Universe of Pre-Filled Syringes and Injection Devices Conference

Whitehouse Laboratories, a Division of Albany Molecular Research Inc., is excited to announce that it will be exhibiting at the Parenteral Drug Association's Universe of Pre-Filled Syringes and Injection...

Global Drug Discovery Market Report 2016-2022 - Analysis, Technologies & Forecasts - Key Vendors: Infosys, Charles River Labs, Albany Molecular Research - Research and Markets

Research and Markets has announced the addition of the "Global Drug Discovery Market Analysis 2016 - Forecast to 2022" report to their offering.

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Albany Molecular Research is an integrated provider of drug discovery and development, chemistry research and manufacturing services. They offer services traditionally provided by chemistry divisions within pharmaceutical and biotechnology companies, including drug discovery, medicinal chemistry, chemical...

See More

Support & Resistance

2nd Resistance Point 18.76
1st Resistance Point 18.45
Last Price 18.14
1st Support Level 17.92
2nd Support Level 17.70

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.